Simulation of quality-adjusted survival in chronic diseases: an application in type 2 diabetes. by Hayes, A, Clarke, P, Voysey, M, Keech, A

Evaluating U-series tools for weathering rate and duration on a soil sequence of known ages by Keech, A, West, A, Pett-Ridge, J, Henderson, G

Calibrating U-series tools for weathering rate and duration on a soil sequence of known ages by Keech, A, Pett-Ridge, J, West, A, Henderson, G

EFFECT OF TRANSPORT CONDITIONS ON LIPID STABILITY IN EPIDEMIOLOGIC STUDIES by Keech, A, Slade, M, Chen, Z, Slavin, B, Kearney, E

Statins and diabetes - Authors' reply by Kearney, P, Keech, A, Simes, J, Collins, R, Baigent, C

Statins for people at low risk of cardiovascular disease reply by Mihaylova, B, Emberson, J, Keech, A, Collins, R, Baigent, C, Cholesterol, T

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration. Oxford Cholesterol Study Group. by Wardle, J, Armitage, J, Collins, R, Wallendszus, K, Keech, A, Lawson, A

Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration by Wardle, J, Armitage, J, Collins, R, Wallendszus, K, Keech, A, Lawson, A

Efficacy and safety of more intensive lowering of LDL cholesterol Reply by Baigent, C, Emberson, J, Blackwell, L, Keech, A, Collins, R, Trialists, C

Efficacy and safety of cholesterol-lowering treatment - Reply by Baigent, C, Keech, A, Kearney, P, Collins, R, Simes, J, Collaboration, CTT

Efficacy and safety of cholesterol-lowering treatment - Reply by Baigent, C, Keech, A, Kearney, P, Collins, R, Simes, J, Collaboration, CTT

Can self-rated health scores be used for risk prediction in patients with type 2 diabetes? by Hayes, A, Clarke, P, Glasziou, P, Simes, R, Drury, P, Keech, A

Statins and diabetes - Reply by Kearney, P, Keech, A, Simes, J, Collins, R, Baigent, C, Collaboration, CTT

Efficacy and safety of more intensive lowering of LDL cholesterol Reply by Baigent, C, Emberson, J, Blackwell, L, Keech, A, Collins, R, Trialists, C

Using the EQ-5D index score as a predictor of outcomes in patients with type 2 diabetes. by Clarke, P, Hayes, A, Glasziou, P, Scott, R, Simes, J, Keech, A

Absence of effects of prolonged simvastatin therapy on nocturnal sleep in a large randomized placebo-controlled study. Oxford Cholesterol Study Group. by Keech, A, Armitage, J, Wallendszus, K, Lawson, A, Hauer, A, Parish, S, Collins, R

Prolonged infection with hepatitis B virus and association between low blood cholesterol concentration and liver cancer. by Chen, Z, Keech, A, Collins, R, Slavin, B, Chen, J, Campbell, T, Peto, R

Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study: baseline characteristics and short-term effects of fenofibrate [ISRCTN64783481]. by Scott, R, Best, J, Forder, P, Taskinen, MR, Simes, J, Barter, P, Keech, A

Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. by Kearney, P, Blackwell, L, Collins, R, Keech, A, Simes, J, Peto, R, Armitage, J, Baigent, C

Glycemic control over 5 years in 4,900 people with type 2 diabetes: real-world diabetes therapy in a clinical trial cohort. by Best, J, Drury, P, Davis, T, Taskinen, MR, Kesäniemi, Y, Scott, R, Pardy, C, Voysey, M, Keech, A